In November 2006, Merck & Co. Inc. began its high pressure saturation 'One Less' campaign for its genetically engineered drug, GARDASIL, being hailed as a tool to prevent cervical cancer caused by two of...
created by Karen Hatter | 2 years ago | updated 2 years ago 3303 views | 25 recommendations | 8 comments